Genomics and testing of microbiomas based on Hyderabad Mapmygenome received by the Canadian company Microbiom Insights, a worldwide recognized leader in microbial sequencing, in a move aimed at expanding his global presence and deepening scientific abilities.
The acquisition includes a laboratory with the conference of microbiomas in Insights, Canada along with its portfolio of intellectual property. This development will strengthen research and clinical menu Mapmygenome, especially in the areas of metagenomics, transcriptomics and targeted metabolomics. It also means the formal entry of the company to the North American market for the introduction of integrated genomic and microbioma test services throughout the region, the edition said.
The CEO and founder of Mapmygenome Anu Acharya described the acquisition as the main milestone in the company’s global strategy. “The human microbioma is key to health and this acquisition will build us as a leader in this area. It accelerates our North American track and in accordance with our strategic vision of growth through targeted acquisitions leading to our list on the Indian market at the end of this year,” she said.
Malcolm Kendall, CEO of Microbiom Insights, called the merger to improve the quality of services and expand global reach. “The combination of forces with MapMygenome provides resources and ability to offer our clients higher quality services and speed up growth. Combinations of their AI -based genomic solutions and our deep expertise will lead to a new standard of top services for clients around the world,” he said.
Published – 29. May 2025 20:50 is
